======= OTUD7B ======= == Gene Information == * **Official Symbol**: OTUD7B * **Official Name**: OTU deubiquitinase 7B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56957|56957]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6GQQ9|Q6GQQ9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=OTUD7B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20OTUD7B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611748|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Negative regulator of the non-canonical NF-kappa-B pathway that acts by mediating deubiquitination of TRAF3, an inhibitor of the NF-kappa-B pathway, thereby acting as a negative regulator of B-cell responses. In response to non-canonical NF- kappa-B stimuli, deubiquitinates 'Lys-48'-linked polyubiquitin chains of TRAF3, preventing TRAF3 proteolysis and over-activation of non-canonical NF-kappa-B. Negatively regulates mucosal immunity against infections (By similarity). Deubiquitinates ZAP70, and thereby regulates T cell receptor (TCR) signaling that leads to the activation of NF-kappa-B (PubMed:26903241). Plays a role in T cell homeostasis and is required for normal T cell responses, including production of IFNG and IL2 (By similarity). Mediates deubiquitination of EGFR (PubMed:22179831). Has deubiquitinating activity toward 'Lys-11', 'Lys-48' and 'Lys-63'-linked polyubiquitin chains (PubMed:27732584). Has a much higher catalytic rate with 'Lys-11'-linked polyubiquitin chains (in vitro); however the physiological significance of these data are unsure (PubMed:27732584). Hydrolyzes both linear and branched forms of polyubiquitin. {ECO:0000250|UniProtKB:B2RUR8, ECO:0000269|PubMed:11463333, ECO:0000269|PubMed:12682062, ECO:0000269|PubMed:18178551, ECO:0000269|PubMed:20622874, ECO:0000269|PubMed:22179831, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:27732584}. |OTU| |protein deubiquitination involved in ubiquitin-dependent protein catabolic process| |protein K11-linked deubiquitination| |Lys48-specific deubiquitinase activity| |negative regulation of interleukin-8 production| |K63-linked polyubiquitin modification-dependent protein binding| |mucosal immune response| |negative regulation of protein localization to nucleus| |cysteine-type peptidase activity| |protein K63-linked deubiquitination| |organ or tissue specific immune response| |protein K48-linked deubiquitination| |negative regulation of I-kappaB kinase/NF-kappaB signaling| |thiol-dependent ubiquitinyl hydrolase activity| |regulation of interleukin-8 production| |thiol-dependent ubiquitin-specific protease activity| |negative regulation of cellular protein localization| |regulation of protein localization to nucleus| |regulation of I-kappaB kinase/NF-kappaB signaling| |negative regulation of cytokine production| |protein deubiquitination| |protein modification by small protein removal| |in utero embryonic development| |negative regulation of intracellular signal transduction| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |regulation of cellular protein localization| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |adaptive immune response| |cellular protein catabolic process| |chordate embryonic development| |embryo development ending in birth or egg hatching| |protein catabolic process| |regulation of cytokine production| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |cellular macromolecule catabolic process| |regulation of cellular localization| |embryo development| |protein modification by small protein conjugation or removal| |regulation of protein localization| |macromolecule catabolic process| |organonitrogen compound catabolic process| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |proteolysis| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of response to stimulus| |negative regulation of gene expression| |organic substance catabolic process| |cellular catabolic process| |regulation of intracellular signal transduction| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp293|Myriocin 25μM R06 exp293]]|-2.36| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-1.72| |[[:results:exp83|Trametinib 10μM R02 exp83]]|1.83| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.89| |[[:results:exp113|1-Methyl-nicotinamide-chloride 1000μM R03 exp113]]|1.95| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7516 * **Expression level (log2 read counts)**: 3.4 {{:chemogenomics:nalm6 dist.png?nolink |}}